Arcutis Biotherapeutics publishes update to financial calendar

• Arcutis Biotherapeutics will report third-quarter 2026 results Nov. 4 following the U.S. market close.
• A business update is scheduled for the same day, with a conference call and webcast at 4:30 p.m. ET.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610211600PRIMZONEFULLFEED9847737) on October 21, 2026, and is solely responsible for the information contained therein.